AFC-HD AMS Life Science Co. Ltd. said its normalized net income for the fiscal first quarter ended Nov. 30, 2014, was ¥8.72 per share, a decline of 17.6% from ¥10.58 per share in the prior-year period.
Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was ¥104.1 million, a decrease of 17.1% from ¥125.6 million in the prior-year period.
The normalized profit margin declined to 3.1% from 3.6% in the year-earlier period.
Total revenue fell on an annual basis to ¥3.37 billion from ¥3.46 billion, and total operating expenses decreased from the prior-year period to ¥3.20 billion from ¥3.24 billion.
Reported net income decreased 22.5% from the prior-year period to ¥100.0 million, or ¥8.33 per share, from ¥129.0 million, or ¥10.86 per share.
As of Jan. 14, US$1 was equivalent to ¥116.84.
